Skip to main content
. Author manuscript; available in PMC: 2017 Jul 12.
Published in final edited form as: Circulation. 2016 Jun 30;134(2):153–167. doi: 10.1161/CIRCULATIONAHA.116.022304

Figure 8.

Figure 8

β2AR re-expression on reconstituted β2ARKO BM reverses splenic retention of leukocytes. (A) Representative CD68, tryptase and MPO staining of spleens from β2ARKO+GFP and β2ARKO+β2AR BMT mice 4d post-MI. (B) Quantification of CD68, tryptase and MPO staining from the spleens from (A). n=8 β2ARKO+GFP BMT and n=8 β2ARKO+β2AR BMT, Exact Wilcoxon rank-sum tests, † p < 0.01, ‡ p < 0.001 vs β2ARKO+GFP BMT. (C) Representative CD68, tryptase and MPO staining of the border zone of hearts from β2ARKO+GFP and β2ARKO+β2AR BMT animals 4d following MI surgery. (D) Quantification of CD68, tryptase and MPO staining from the border zone of 4d post-MI hearts from β2ARKO+GFP (n=8) and β2ARKO+β2AR BMT (n=6) mice. Exact Wilcoxon rank-sum tests, ‡ p < 0.001 vs β2ARKO+GFP BMT.